Related Experiment Video
Updated: Jun 20, 2026
13:58
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
Efficient methodologies for sensitive HIV-1 RNA quantitation from plasma and vaginal secretions
Tara Randolph Henning1, Nedra Lacour, Angela Martin Amedee
1Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
Summary
A new, cost-effective assay accurately quantifies HIV RNA in blood and vaginal secretions. This method is reliable for clinical research, aiding HIV prevention and transmission studies.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Accurate quantification of HIV levels in mucosal secretions is crucial for understanding viral compartmentalization.
- This is essential for developing effective HIV intervention and transmission prevention strategies.
Purpose of the Study:
- To develop a sensitive, reliable, and cost-effective method for quantifying HIV in blood and vaginal secretions.
- The technique should be suitable for clinical research settings.
Main Methods:
- Developed a real-time reverse transcriptase (RT) PCR assay targeting the HIV-1 pol gene (Hpol assay).
- Compared the Hpol assay to the Roche Amplicor HIV-1 Monitor assay for plasma and genital secretions.
- Evaluated simplified sample collection and processing methods for genital secretions.
Main Results:
- The Hpol assay demonstrated high sensitivity and reliability, correlating well with the Roche Amplicor assay (R²=0.9179 for plasma, R²=0.942 for vaginal secretions).
- The assay can reproducibly quantify as low as 5 HIV-1 RNA copies per reaction with minimal variation.
- No significant difference in vaginal viral load detection was observed between simplified and provider-based sample collection/processing methods.
Conclusions:
- The developed Hpol assay offers a sensitive, reliable, and cost-effective method for quantifying HIV in plasma and mucosal secretions.
- These methodologies are well-suited for efficient implementation in clinical research studies.
